Premium
Penetrance estimation of TTR familial amyloid polyneuropathy (type I) in Brazilian families
Author(s) -
Saporta M. A. C.,
Zaros C.,
Cruz M. W.,
André C.,
Misrahi M.,
BonaïtiPellié C.,
PlantéBordeneuve V.
Publication year - 2009
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/j.1468-1331.2008.02429.x
Subject(s) - penetrance , transthyretin , medicine , genotyping , polyneuropathy , amyloid polyneuropathy , population , age of onset , genetics , genotype , phenotype , gene , disease , biology , environmental health
Background and purpose: Familial amyloid polyneuropathy (FAP) type I is a severe autosomal dominant inherited neuropathy associated with mutations in the transthyretin (TTR) gene. Significant phenotypic variability is seen amongst families with distinct geographic origin, especially regarding penetrance and age of onset. The aim of this study was to estimate the penetrance of FAP in Brazilian families. Methods: Twenty‐two distinct families were ascertained through genetically confirmed index cases and included in this study. Genealogical and clinical data were obtained from a total of 623 individuals, including 126 affected by FAP. In 15 families, TTR genotyping was performed in all available relatives ( n = 86), after informed written consent. Seven families did not consent for genetic testing, but agreed to provide clinical and genealogical data. Penetrance was estimated using a previously described method based on survival analysis and corrected for ascertainment bias. Results: Mean age of onset in our sample was 34.5 years, with a significant earlier onset in males (31.1 vs. 35.9, P < 0.0001). The penetrance of FAP in our sample was estimated as 83% (95% CI: 66–99) after 60 years. Conclusion: Our results provide new information on FAP in Brazilian patients and may be helpful in the genetic counseling of this population.